Multiple chemical sensitivity (MCS) - a guide for dermatologists on how to manage affected individuals.
Multiple chemical sensitivity (MCS) – a guide for dermatologists on how to manage affected individuals.
J. Dtsch. Dermatol. Ges. 18, 119-131 (2020)
Multiple chemical sensitivity (MCS) is a condition characterized by a subjectively perceived increase in sensitivity to environmental chemicals. Individuals affected report a wide variety of nonspecific complaints, and frequently attribute cutaneous and mucosal symptoms to chemical exposures. Dermatologists should therefore be familiar with this condition. MCS is a diagnosis of exclusion. Other causes for the patients' symptoms should be ruled out by routine laboratory tests, allergy tests and, if indicated, monitoring for toxic (environmental) substances. The primary job of dermatologists is to rule out skin diseases or hypersensitivities as possible causes of the complaints. Interdisciplinary patient management is essential, especially in severe cases in which those affected have problems coping with everyday life. Relevant specialties in this context include environmental medicine, psychosomatic medicine as well as occupational and social medicine. Cutaneous symptoms are usually addressed with symptomatic treatment using basic skin care products. There are currently no evidence-based treatment recommendations for MCS. It is crucial that MCS patients be protected from unnecessary treatments and thus from mental, social and financial strain. In addition to medical skills, managing MCS patients requires communicative and psychosocial competence in particular. Physicians involved in the treatment will benefit from training in psychotherapy. Irrespective of the mechanisms that lead to MCS, diagnosis and treatment of this condition require an actively supportive attitude towards these patients, a good doctor-patient relationship and interdisciplinary cooperation.
Multiple chemical sensitivity (MCS) is a condition characterized by a
subjectively perceived increase in sensitivity to environmental
chemicals. Individuals affected report a wide variety of nonspecific
complaints, and frequently attribute cutaneous and mucosal symptoms to
chemical exposures. Dermatologists should therefore be familiar with
this condition. MCS is a diagnosis of exclusion. Other causes for the
patients' symptoms should be ruled out by routine laboratory tests,
allergy tests and, if indicated, monitoring for toxic (environmental)
substances. The primary job of dermatologists is to rule out skin
diseases or hypersensitivities as possible causes of the complaints.
Interdisciplinary patient management is essential, especially in severe
cases in which those affected have problems coping with everyday life.
Relevant specialties in this context include environmental medicine,
psychosomatic medicine as well as occupational and social medicine.
Cutaneous symptoms are usually addressed with symptomatic treatment
using basic skin care products. There are currently no evidence-based
treatment recommendations for MCS. It is crucial that MCS patients be
protected from unnecessary treatments and thus from mental, social and
financial strain. In addition to medical skills, managing MCS patients
requires communicative and psychosocial competence in particular.
Physicians involved in the treatment will benefit from training in
psychotherapy. Irrespective of the mechanisms that lead to MCS,
diagnosis and treatment of this condition require an actively supportive
attitude towards these patients, a good doctor-patient relationship and
interdisciplinary cooperation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Intolerance; Environment; Symptoms; Disease; Odor
Keywords plus
Language
german
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
1610-0379
e-ISSN
1610-0387
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 18,
Issue: 2,
Pages: 119-131
Article Number: ,
Supplement: ,
Series
Publisher
Blackwell
Publishing Place
Chichester
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Environmental Medicine (IEM)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Allergy
PSP Element(s)
G-503400-001
Grants
Copyright
Erfassungsdatum
2020-03-13